Profile
Jennifer Fitzpatrick is currently the Vice President & Corporate Counsel at SAGE Therapeutics, Inc. She previously worked as Secretary & Director at Aegerion Pharmaceuticals, Inc.
Jennifer Fitzpatrick active positions
| Companies | Position | Start |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Former positions of Jennifer Fitzpatrick
| Companies | Position | End |
|---|---|---|
| AEGERION PHARMACEUTICALS, INC. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SAGE THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Jennifer Fitzpatrick
